MENU
HURA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TuHURA Biosciences (HURA) Ownership - Who owns TuHURA Biosciences?
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy... Show more
Profile
Industry
N/A
Address
10500 University Center Drive
Phone
+1 813 875-6600
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
184.77M
P/E Ratio
N/A
Total Cash
3.02M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
HURA
Capitalization
185M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.02M
Total Cash/Share
0.07
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
1.42M
P/B Ratio
12.90
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.54
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
10M
Shares Outstanding - Current
43.7M
Total Liabilities
2.45M
Total Volume MTD
N/A
Value
-1
Gain YTD
3.423
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
10500 University Center Drive
Phone
+1 813 875-6600
Employees
N/A
Web
N/A